Histopathologic Characterization of Lung Adenocarcinoma in Relation to Fluorine-18-fluorodeoxyglucose Uptake on Positron Emission Tomography

被引:11
作者
Domen, Hiromitsu [1 ,2 ]
Hida, Yasuhiro [3 ]
Okamoto, Shozo [4 ]
Hatanaka, Kanako C. [1 ]
Hatanaka, Yutaka [1 ]
Kaga, Kichizo [3 ]
Tamaki, Nagara [4 ]
Hirano, Satoshi [2 ]
Matsuno, Yoshihiro [1 ]
机构
[1] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 0608648, Japan
[2] Hokkaido Univ, Dept Gastroenterol Surg 2, Grad Sch Med, Sapporo, Hokkaido, Japan
[3] Hokkaido Univ, Dept Cardiovasc & Thorac Surg, Grad Sch Med, Sapporo, Hokkaido, Japan
[4] Hokkaido Univ, Dept Nucl Med, Grad Sch Med, Sapporo, Hokkaido, Japan
关键词
fluorine-19-fluorodeoxyglucose; positron emission tomography; lung adenocarcinoma; maximum standardized uptake value; histopathology; FDG-PET; PROGNOSTIC VALUE; BRONCHIOLOALVEOLAR CARCINOMA; FLUORODEOXYGLUCOSE UPTAKE; PULMONARY ADENOCARCINOMA; F-18-FDG PET; CANCER; SURVIVAL; STAGE; RESECTION;
D O I
10.1093/jjco/hyt100
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fluorine-18-fluorodeoxyglucose uptake on positron emission tomography is reported to have prognostic significance in patients after resection of lung adenocarcinoma. However, its relationship with histopathologic features remains unknown. We conducted a retrospective analysis of 205 patients who had undergone surgical resection of primary lung adenocarcinoma (1.0 cm) after preoperative fluorine-18-fluorodeoxyglucose-positron emission tomography between January 1999 and December 2008 at Hokkaido University Hospital. Fluorine-18-fluorodeoxyglucose uptake was measured by the maximum standardized uptake value. A histopathologic review was performed according to the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification, and various histopathologic factors were evaluated semi-quantitatively. Correlations between these clinicopathologic factors and the maximum standardized uptake value (high 2.0 vs low 2.0) were analyzed. Univariate analysis of clinicopathologic factors demonstrated that the following were significantly correlated with a high maximum standardized uptake value: an elevated carcinoembryonic antigen level, larger tumor size, upgraded pT, pN, pStage, non-lepidic histology, abundant fibroblastic/hyalinized stroma, necrosis, presence of pleural involvement, lymphatic and vascular invasion and more intra- and extracellular mucin. Multivariate analysis demonstrated that a tumor size of 2.0 cm, non-lepidic histology and abundant fibroblastic/hyalinized stroma were significantly correlated with the high maximum standardized uptake value. More histopathologic factors are known to correlate with poor prognosis in lung adenocarcinomas showing high maximum standardized uptake values than in those showing low maximum standardized uptake values. Therefore, prognostication of patients with a resectable lung adenocarcinoma on the basis of preoperative fluorine-18-fluorodeoxyglucose uptake is histopathologically valid. Such observations may also help us to clarify the pathobiological mechanism responsible for the increased fluorine-18-fluorodeoxyglucose uptake in lung adenocarcinomas with a poor prognosis.
引用
收藏
页码:874 / 882
页数:9
相关论文
共 35 条
[1]   Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC) -: A systematic review and meta-analysis (MA) by the European lung cancer working party for the IASLC lung cancer staging project [J].
Berghmans, Thierry ;
Dusart, Michele ;
Paesmans, Marianne ;
Hossein-Foucher, Claude ;
Buvat, Irene ;
Castaigne, Catherine ;
Scherpereel, Arnaud ;
Mascaux, Celine ;
Moreau, Michel ;
Roelandts, Martine ;
Alard, Stphane ;
Meert, Anne-Pascale ;
Patz, Edward F., Jr. ;
Lafitte, Jean-Jacques ;
Sculier, Jean-Paul .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (01) :6-12
[2]   Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection [J].
Downey, RJ ;
Akhurst, T ;
Gonen, M ;
Vincent, A ;
Bains, MS ;
Larson, S ;
Rusch, V .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3255-3260
[3]   Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer [J].
Duarte, IG ;
Bufkin, BL ;
Pennington, MF ;
Gal, AA ;
Cohen, C ;
Kosinski, AS ;
Mansour, KA ;
Miller, JI .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 115 (03) :652-658
[4]   Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma [J].
Ebright, MI ;
Zakowski, MF ;
Martin, J ;
Venkatraman, ES ;
Miller, VA ;
Bains, MS ;
Downey, RJ ;
Korst, RJ ;
Kris, MG ;
Rusch, VW .
ANNALS OF THORACIC SURGERY, 2002, 74 (05) :1640-1647
[5]   Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology [J].
Emmering, J. ;
Krak, N. C. ;
Van der Hoeven, J. J. M. ;
Spreeuwenberg, M. D. ;
Twisk, J. W. R. ;
Meijer, S. ;
Pinedo, H. M. ;
Hoekstra, O. S. .
ANNALS OF ONCOLOGY, 2008, 19 (09) :1573-1577
[6]  
HARPOLE DH, 1995, CANCER-AM CANCER SOC, V76, P787, DOI 10.1002/1097-0142(19950901)76:5<787::AID-CNCR2820760512>3.0.CO
[7]  
2-Q
[8]   FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features [J].
Higashi, K ;
Ueda, Y ;
Ayabe, K ;
Sakurai, A ;
Seki, H ;
Nambu, Y ;
Oguchi, M ;
Shikata, H ;
Taki, S ;
Tonami, H ;
Katsuda, S ;
Yamamoto, I .
NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (08) :707-714
[9]   Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: A heterogeneous disease [J].
Hsu, Chung-Ping ;
Hsia, Jiun-Yi ;
Chang, Gee-Chen ;
Chuang, Cheng-Yen ;
Shai, Sen-Ei ;
Yang, Shyh-Sheng ;
Lee, Ming-Ching ;
Kwan, Po-Cheung .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (02) :426-433
[10]   FDG-PET SUVmax Combined with IASLC/ATS/ERS Histologic Classification Improves the Prognostic Stratification of Patients with Stage I Lung Adenocarcinoma [J].
Kadota, Kyuichi ;
Colovos, Christos ;
Suzuki, Kei ;
Rizk, Nabil P. ;
Dunphy, Mark P. S. ;
Zabor, Emily C. ;
Sima, Camelia S. ;
Yoshizawa, Akihiko ;
Travis, William D. ;
Rusch, Valerie W. ;
Adusumilli, Prasad S. .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (11) :3598-3605